News Breaks |
|
|
| March 11, 2013 |
| 04:55 EDT |  | PFE, PFE, PFE, PFE, TEVA, TEVA, TEVA, TEVA, MYL, MYL, MYL, MYL, BASFY, BASFY, BASFY, BASFY, LLY, LLY, LLY, LLY, AMGN, AMGN, AMGN, AMGN, ABT, ABT, ABT, ABT, BIIB, BIIB, BIIB, BIIB, GSK, GSK, GSK, GSK | Drug, Chemical & Associated Technologies Association to host conference
DCAT Week 2013 is being held in New York on March 11-14. |
|
|
News For PFE;TEVA;MYL;BASFY;LLY;AMGN;ABT;BIIB;GSK From The Last 14 Days Check below for free stories on PFE;TEVA;MYL;BASFY;LLY;AMGN;ABT;BIIB;GSK the last two weeks. |
|
|
| May 23, 2013 |
| 12:37 EDT | | BASFY | BASF management to meet with Jefferies
Meeting to be held in Boston on May 30 hosted by Jefferies. |
|
| 08:04 EDT |  | BIIB | Biogen appoints Spyros Artavanis-Tsakonas as Chief Scientific Officer
 Subscribe for More Information |
|
| 07:58 EDT |  | BASFY | BASF eyes India for global research center, Economic Times reports
Subscribe for More Information |
|
| May 22, 2013 |
| 16:23 EDT | | TEVA | Alexza Pharmaceuticals chief commercial officer to leave company
Subscribe for More Information |
|
| 11:53 EDT |  | MYL | High option volume stocks: UAN MYL ALNY SKS XIDE
Subscribe for More Information |
|
| 08:59 EDT | | PFE | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:25 EDT | | GSK | GlaxoSmithKline awarded up to $200M by U.S. to develop new antibiotics
Subscribe for More Information |
|
| 08:06 EDT | | PFE | Zoetis comments on Pfizer’s split-off plans for remaining interest
Subscribe for More Information |
|
| 08:04 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
| |
| 07:28 EDT | | ABT | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| May 21, 2013 |
| 08:03 EDT | | ABT | Abbott announces CE Mark for coronary drug eluting stent
Subscribe for More Information |
|
| 07:44 EDT | | GSK | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:35 EDT | | MYL | Mylan: Appellate Court rules in favor of company in patent infringement case
Subscribe for More Information |
|
| 07:24 EDT | | BIIB, LLY | Global Health Care to host a conference
Subscribe for More Information |
|
| 07:16 EDT | | PFE | Pfizer management to meet with Leerink
Subscribe for More Information |
|
| 07:07 EDT |  | GSK | Theravance pullback on Elan bid a buying opportunity, says Piper Jaffray
Subscribe for More Information |
|
| 05:44 EDT | | BIIB | Biogen submits application to FDA for approval of Plegridy in RMS
Subscribe for More Information |
|
| May 20, 2013 |
| 17:04 EDT | | PFE | Pfizer discontinues phase 3 study of inotuzumab ozogamicin
Subscribe for More Information |
|
| 15:57 EDT | | BIIB | Biogen IMS numbers should not be adjusted down at ISI Group
ISI Group confirmed with Biogen that Tecfidera is not captured by IMS and numbers should not be adjusted downward to reflect free drugs dispensed. |
| |
|
|
|
|
